Biogen agrees to buy Reata Pharmaceuticals for $172.50 a share in cash
selvanegra/iStock via Getty Images Biogen Inc. (NASDAQ:BIIB) agreed to buy Reata Pharmaceuticals (NASDAQ:RETA) for $172.50 per share in cash, or ...
- Latest
- Trending
selvanegra/iStock via Getty Images Biogen Inc. (NASDAQ:BIIB) agreed to buy Reata Pharmaceuticals (NASDAQ:RETA) for $172.50 per share in cash, or ...
Welcome to wdctv.news, your one stop for breaking news and in-depth coverage of the most happening events around the world. WDC TV NEWS Breaking News